Q1. How many patients have been treated (for any condition) in the last four months with:
a. Benralizumab
b. Dupilumab
c. Omalizumab
d. Reslizumab
e. Mepolizumab
Q2. Of the total patients treated in the last four months with any of the products listed in Q1, please can you provide the split of the number of patients in the following age groups:
a. Age 6-11
b. Age 12-17
c. Age 18 and above
Q3. How many patients have been treated in the last four months for asthma ONLY with:
a. Dupilumab
Download response Biologic products in respiratory medicine. 100921.docx